In Vitro Xanthine Oxidase Inhibitory Activity of Morinda citrifolia L. (Noni) Leaf and Identification of Its Xanthine Oxidase Inhibitors

Authors

  • Jaturon Thipwong Biology Program, Faculty of Science and Technology, Suratthani Rajabhat University, Surat Thani 84100, Thailand https://orcid.org/0000-0003-3179-2875
  • Kittima Kongton Biology Program, Faculty of Science and Technology, Suratthani Rajabhat University, Surat Thani 84100, Thailand
  • Benjamas Nupan Biology Program, Faculty of Science and Technology, Suratthani Rajabhat University, Surat Thani 84100, Thailand

DOI:

https://doi.org/10.48048/tis.2023.4201

Keywords:

Morinda citrifolia leave, Xanthine oxidase, Phenolic compounds, LC-MS, XO inhibitors

Abstract

Hyperuricemia causes an excessive level of uric acid in the body, which leads to the formation of gouty arthritis and high uric acid-related diseases. To cure this condition, xanthine oxidase (XO), a key enzyme in uric acid production, was targeted. A routinely used XO inhibitor drug, allopurinol, has side effects. Therefore, an alternative XO inhibitor with a high activity and fewer side effects is strongly desired. In this research, we evaluated the XO inhibitory activity of Morinda citrifolia L. (noni) leaves extracted using 2 solvents, 95 % ethanol and water. The total phenolic and flavonoid content was analyzed. Moreover, the phenolic profile was investigated using liquid column chromatography-mass spectrometry (LC-MS). The results showed that at a concentration of 100 µg mL−1, the ethanolic (McE) and water (McW) extracts could exhibit XO inhibitory activity above 90 %, and the IC50 values predicted using dose-response logarithmic function curves were 2.24 ± 0.2 and 7.2 ± 0.1 µg mL−1, respectively, while the IC50 of allopurinol was 1.02 ± 0.1 µg mL−1. The total phenolic and flavonoid content in McE was higher than that in McW. LC-MS analysis revealed that all extracts contained several phenolic compounds. Interestingly, known potent XO inhibitors were found in both extracts. Kaempferol, esculetin, saponarin, physcion and g-aminobutyric acid were found in McE, while McW contained esculetin, saponarin and rutin. Taken together, M. citrifolia L. leaves could be used as an effective alternative XO inhibitor for curing hyperuricemia and high uric acid-related diseases caused by XO activity.

HIGHLIGHTS

  • The XO inhibitory activity of Morinda citrifolia (noni) leaves was reported for the first time
  • An ethanolic leaf extract (McE) contained higher total phenolic and total flavonoid content than a water extract (McW)
  • Both noni extracts contained the known potent XO inhibitor by kaempferol, esculetin, saponarin, physcion and g-aminobutyric acid were also found in McE, while, McW contained esculetin, rutin, and saponarin


GRAPHICAL ABSTRACT 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

P Richette and T Bardin. Gout. Lancet 2010; 375, 318-28.

D Grassi, L Ferri, G Desideri, P Di Giosia, P Cheli, R Del Pinto, G Properzi and C Ferri. Chronic hyperuricemia, uric acid deposit and cardiovascular risk. Curr. Pharm. Des. 2013; 19, 2432-8.

KG Saag and H Choi. Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res. Ther. 2006; 8, S2.

RA Brook, A Forsythe, JE Smeeding and N Lawrence Edwards. Chronic gout: Epidemiology, disease progression, treatment and disease burden. Curr. Med. Res. Opin. 2010; 26, 2813-21.

G Luna, AV Dolzhenko and RL Mancera. Inhibitors of xanthine oxidase: scaffold diversity and structure-based drug design. Chem. Med. Chem. 2019; 14, 714-43.

A Umpiérrez, J Cuesta-Herranz, MDL Heras, M Lluch-Beranal, E Figueredo and J Sastre. Successful desensitization of a fixed drug eruption caused by allopurinol. J. Allergy Clin. Immunol. 1998; 101, 286-93.

N Maddu. Diseases related to types of free radicals. IntechOpen, London, 2019, p. 418.

RM Fagugli, G Gentile, G Ferrara and R Brugnano. Acute renal and hepatic failure associated with allopurinol treatment. Clin. Nephrol. 2008; 70, 523-9.

G Schmeda-Hirschmann, J Zúñiga, M Dutra-Behrens and G Habermehl. Xanthine oxidase inhibitory activity of flavonoids and tannins from Hexachlamys edulis (Myrtaceae). Phytother. Res. 1998; 10, 260-2.

S Lin, G Zhang, Y Liao, J Pan and D Gong. Dietary flavonoids as xanthine oxidase inhibitors: Structure-affinity and structure-activity relationships. J. Agric. Food Chem. 2015; 63, 7784-94.

Y Wang, G Zhang, J Pan and D Gong. Novel insights into the inhibitory mechanism of kaempferol on xanthine oxidase. J. Agric. Food Chem. 2015; 63, 526-34.

M Yuan, Y Liu, A Xiao, J Leng, L Liao, L Ma and L Liu. The interaction of dietary flavonoids with xanthine oxidase in vitro: Molecular property-binding affinity relationship aspects. RSC Adv. 2019; 9, 10781-8.

C Spanou, AS Veskoukis, T Kerasioti, M Kontou, A Angelis, N Aligiannis, AL Skaltsounis and Kouretas. Flavonoid glycosides isolated from unique legume plant extracts as novel inhibitors of xanthine oxidase. Plos One. 2012; 7, e32214.

MEMB de Araujo, YEM Francoa, TG Alberto, MCF Messias, CW Leme, ACHF Sawaya and PO Carvalho. Kinetic study on the inhibition of xanthine oxidase by acylated derivatives of flavonoids synthesised enzymatically. J. Enzyme Inhib. Med. Chem. 2017; 32, 978-85.

HC Lin, SH Tsai, CS Chen, YC Chang, CM Lee, ZY Lai and CM Lin. Structure-activity relationship of coumarin derivatives on xanthine oxidase-inhibiting and free radical-scavenging activities. Biochem. Pharmacol. 2008; 75, 1416-25.

E Hofmann, J Webster, T Kidd, R Kline, M Jayasinghe and S Paula. Coumarins with xanthine oxidase inhibiting and radical scavenging properties: tools to combat oxidative stress in cells. Int. J. Biosci. Biochem. Bioinforma. 2014; 4, 234-9.

A Fais, B Era, S Asthana, V Sogos, R Medda, L Santana, E Uriarte, MJ Matos, F Delogu and A Kumar. Coumarin derivatives as promising xanthine oxidase inhibitors. Int. J. Biol. Macromol. 2018; 120,1286-93.

NA Aladdin, K Husain, J Jalil, CW Sabandar and JA Jamal. Xanthine oxidase inhibitory activity of a new isocoumarin obtained from Marantodes pumilum var. pumila leaves. BMC Complement. Med. Ther. 2020; 20, 324.

P Nandhasri, KK Pawa, J Kaewtubtim, C Jeamchanya, C Jansom and C Sattaponpun. Nutraceutical properties of Thai "Yor", Morinda citrifolia and "Noni" juice extract. Songklanakarin J. Sci. Technol. 2005; 27, 579-86.

A Hirazumi, E Furusawa, SC Chou and Y Hokama. Immunomodulation contributes to the anticancer activity of Morinda citrifolia (noni) fruit juice. Proc. West. Pharmacol. Soc. 1996; 39, 7-9.

S Nayak, M Chintamaneni and S Mengi. Anti-infective potential of Morinda citrifolia fruit extract. Int. J. Pharm. Pharm. Sci. 2011; 3, 81-83.

A Bramorski, AR Cherem, CP Marmentini, J Torresani, T Mezadri and AA Costa. Total polyphenol content and antioxidant activity of commercial Noni (Morinda citrifolia L.) juice and its components. Brazillian J. Pharm. Sci. 2010; 46, 651-6.

W Thani, O Vallisuta, P Siripong and N Ruangwises. Anti-proliferative and antioxidative activities of Thai noni/Yor (Morinda citrifolia Linn.) leaf extract. Southeast Asian J. Trop. Med. Public Health 2010; 41, 482-9.

S Basar, K Uhlenhut, P Högger, F Schöne and J Westendorf. Analgesic and antiinflammatory activity of Morinda citrifolia L. (Noni) fruit. Phytother. Res. 2010; 24, 38-42.

A Palu, S Deng, B West and J Jensen. Xanthine oxidase inhibiting effects of Noni (Morinda citrifolia) fruit juice. Phytother. Res. 2009; 23, 1790-1.

NQ Nguyen, MT Nguyen, VT Nguyen, VM Le, LH Trieu, XT Le, TV Khang, NTL Giang, NQ Thach and TT Hung. The effects of different extraction conditions on the polyphenol, flavonoids components and antioxidant activity of Polyscias fruticosa roots. IOP Conf. Ser.: Mater. Sci. Eng. 2020; 736, 022067.

TI Maulana, S Falah and D Andrianto. Total phenolic content, total flavonoid content, and antioxidant activity of water and ethanol extract from Surian (Toona sinensis) leaves. IOP. Conf. Ser.: Earth Environ. Sci. 2019; 299: 012021.

S Azmi, P Jamal and A Amid. Xanthine oxidase inhibitory activity from potential Malaysian medicinal plant as remedies for gout. Int. Food Res. J. 2012; 19, 159-65.

P Terpinc, B Cigic, T Polak, J Hribar and T Pozrl. LC-MS analysis of phenolic compounds and antioxidant activity of buckwheat at different stages of malting. Food Chem. 2016; 210, 9-17.

N Malik, P Dhiman and A Khatkar. In silico design and synthesis of targeted rutin derivatives as xanthine oxidase inhibitors. BMC Chem. 2019; 13, 71.

TN Minh, TM Van, Y Andriana, LT Vinh, DV Hau, DH Duyen and CD Guzman-Gelani. Antioxidant, xanthine oxidase, α-amylase and α-glucosidase inhibitory activities of bioactive compounds from Rumex crispus L. root. Molecules 2019, 24, 3899.

D Liu, D Wang, W Yang and D Meng. Potential anti-gout constituents as xanthine oxidase inhibitor from the fruits of Stauntonia brachyanthera. Bioorg. Med. Chem. 2017; 25, 3562-6.

YH Pyo, JY Hwang and KS Seong. Hypouricemic and antioxidant effects of soy vinegar extracts in hyperuricemic mice. J. Med. Food. 2018; 21, 1299-305.

Downloads

Published

2022-12-20

How to Cite

Thipwong, J., Kongton, K. ., & Nupan, B. . (2022). In Vitro Xanthine Oxidase Inhibitory Activity of Morinda citrifolia L. (Noni) Leaf and Identification of Its Xanthine Oxidase Inhibitors. Trends in Sciences, 20(2), 4201. https://doi.org/10.48048/tis.2023.4201